Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

RR Donnelley Registers 2.1% Sales Growth In Q4

Author: Akanksha Bakshi | February 18, 2022 11:42am

  • RR Donnelley & Sons Co (NYSE:RRD) reported fourth-quarter net sales growth of 2.1% year-over-year to $1.377 billion, +1.9% on an organic basis, in line with the consensus of $1.38 billion.
  • Adjusted EPS declined to $0.58 from $0.71 in 4Q20, missing the consensus of $0.59.
  • The gross margin contracted by 160 bps to 19.8%. The operating income was $37.1 million (-52.5% Y/Y), and the margin contracted by 310 bps to 2.7%.
  • Adjusted EBITDA was $133.2 million compared to $132.6 million a year ago.
  • RRD's cash provided by operating activities was $92.1 million in FY21 compared to $149.8 million a year ago. The company held cash and equivalents of $320.3 million as of December 31, 2021.
  • The company noted necessary regulatory approvals for the Chatham transaction have been obtained, and subject to the stockholder vote scheduled for February 23, 2022, the transaction is expected to close expeditiously after that and as soon as February 25, 2022.
  • RelatedRR Donnelley Gets $11/Share Unsolicited Offer; Sticks With Chatham Deal At This Time.
  • Price Action: RRD shares are trading higher by 0.60% at $10.82 on the last check Friday.

Posted In: RRD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist